| Literature DB >> 36050194 |
Andrea Fernández Coves1, Karene Hoi Ting Yeung2, Ingeborg M van der Putten3, E Anthony S Nelson4.
Abstract
The COVID-19 pandemic has boosted the adoption of digital health technologies such as teleconsultation. This research aimed to assess and compare barriers and facilitators for teleconsultation uptake for primary care practitioners in Hong Kong and the Netherlands and evaluate the role of their different healthcare funding models in this adoption process within the context of the COVID-19 pandemic. A qualitative research following a social constructivist paradigm was performed. The study employed a conceptual framework from Lau and colleagues that identifies four levels of factors influencing change in primary care: (1) external contextual factors; (2) organization-related factors; (3) professional factors; and (4) characteristics of the intervention. The four levels were studied through semi-structured, open-ended interviews with primary care physicians. External factors were additionally assessed by means of a literature review. Hong Kong and the Netherlands showed different penetration rates of teleconsultation. Most stakeholders in both settings shared similar barriers and facilitators in the organizational, professional, and intervention levels. However, external contextual factors (i.e., current teleconsultation legislation, available incentives, and level of public awareness) played an important and differing role in teleconsultation uptake and had a direct effect on the organization, the professionals involved, and the type of technology used. Political and organizational actions are required to develop a comprehensive legal framework for the sustainable development of teleconsultation in both settings.Entities:
Keywords: Health system; Hong Kong; Legislation; Netherlands; Primary care; Teleconsultation
Mesh:
Year: 2022 PMID: 36050194 PMCID: PMC9356914 DOI: 10.1016/j.healthpol.2022.07.012
Source DB: PubMed Journal: Health Policy ISSN: 0168-8510 Impact factor: 3.255
Fig. 1Study selection flow diagram based on the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines.
Overview of participants.
| Participant Number | Location | Setting | Practice | Has successfully implemented teleconsultation? | Preferred type of teleconsultation |
|---|---|---|---|---|---|
| Participant 1 | HK | Private | Group clinic | Yes | Video consultation |
| Participant 2 | HK | Public, Academia | Hospital | Partly | Phone consultation |
| Participant 3 | HK | Private | NGO | Yes | Phone consultation |
| Participant 4 | HK | Public | Clinic | No | – |
| Participant 5 | HK | Private | Solo clinic | No | – |
| Participant 6 | HK | Public | University clinic | In the process of implementation | – |
| Participant 7 | HK | Public, Academia | Hospital | Partly | Phone consultation |
| Participant 8 | NL | Private | Group practice | Yes | Email and phone |
| Participant 9 | NL | Private | Group practice | Yes | Email and phone |
| Participant 10 | NL | Private | Group practice | Yes | Email and phone |
| Participant 11 | NL | Private | Group practice | Yes | Video and email |
| Participant 12 | NL | Private | Solo practice | Yes | Video and email |
| Participant 13 | NL | Private | Group practice | Yes | Video and email |
*HK= Hong Kong, NL= the Netherlands.
External context: comparison of Hong Kong and The Netherlands (✓ Mentioned ✗Not mentioned).
| Category | Barrier (B) or Facilitator (F) | Factor | Hong Kong | The Netherlands | Refs. | Participants |
|---|---|---|---|---|---|---|
| Policy and legislation | B | Restrictive legislative framework | ✓ | [ | 1,2,3,4,5,6,7 | |
| B | Poor/Improvable guidelines | ✓ | ✓ | 1,2,3,7 | ||
| B | Lack of awareness on specific guidelines | ✓ | 8,9,10,11,12,13 | |||
| F | Protective legislative framework | ✓ | [ | 8,9,10,11,12,13 | ||
| F | Presence of guidelines | ✓ | 1,2,3,7 | |||
| F | Fit with national agenda | ✓ | ✓ | [ | 10,13 | |
| F | Government promotion of telehealth | ✓ | [ | None | ||
| F | Presences of supportive policies for ICT use | ✓ | [ | None | ||
| Incentives | B | Lack of financial incentives | ✓ | ✓ | [ | All |
| B | Lack of non-financial incentives | ✓ | ✓ | All | ||
| F | Subsidies for equipment acquisition | ✓ | [ | 8 | ||
| F | External legal training available | ✓ | ✓ | 1,2,3,7,8,9 | ||
| F | Governmental training on teleconsultation uptake and use | ✓ | [ | 8 | ||
| F | Funding for research on telehealth | ✓ | ✓ | [ | None | |
| F | Teleconsultation and telehealth can be reimbursed in primary care | ✓ | [ | None | ||
| F | Increased funding and governmental plans for telehealth promotion, uptake, use, and training | ✓ | [ | None | ||
| Public awareness | B | Patient perception of teleconsultation utility / Limited knowledge/affordability of the elderly | ✓ | ✓ | [ | 4,5,7,8,10,11,12,13 |
| F | Patient fear of COVID-19 infection | ✓ | ✓ | [ | 1,2,4,8,10,11,12,13 | |
| F | Patients preferences | ✓ | ✓ | 1,2,4,8,9,10,11,12,13 | ||
| Dominant paradigm | B | Low prevalence of teleconsultation in the area before COVID-19 | ✓ | ✓ | [ | 4,5,6,8,9,10,11,12 |
| B | Current low prevalence of teleconsultation in the area | ✓ | [ | 1,2,3,4,5,6,7 | ||
| F | Worldwide trend of teleconsultation uptake | ✓ | [ | 2,6,7 | ||
| F | Neighbor country has extended usage of teleconsultation | ✓ | ✓ | [ | None | |
| F | Current high prevalence of teleconsultation in the area | ✓ | [ | 8,9,10,11,12,13 | ||
| Access to care | B | Good access to care | ✓ | 4,5,6 | ||
| F | Limited access to specialists | ✓ | 2 | |||
| Stakeholder buy-in | B | Conflict between GPs and health insurers | ✓ | [ | None | |
| F | Good collaboration between GPs and health insurers | ✓ | [ | None | ||
| F | Government collaboration with research centers, universities, hospitals and public and private organizations | ✓ | ✓ | [ | None | |
| F | Participation on international eHealth projects | ✓ | [ | None | ||
| Infrastructure | F | Good internet connection and digital infrastructure | ✓ | ✓ | [ | None |
| F | Plans on improving internet connection | ✓ | ✓ | [ | None | |
| Technology advances | ||||||
| Economic climate and governmental financing | B | Economy affected by COVID-19 | ✓ | ✓ | [ | None |
| F | Increased funding on healthcare and health research | ✓ | ✓ | [ | None | |
| F | Teleconsultation as a tool for improve sustainability | ✓ | ✓ | [ | None |
Not found in the literature.
Lack of specific guidelines available.
Insufficient.
Only elderly, younger perception was a facilitator.
Organizational level: comparison of Hong Kong and The Netherlands (✓ Mentioned ✗Not mentioned).
| Category | Barrier (B) or Facilitator (F) | Factor | Hong Kong | The Netherlands | Participants |
|---|---|---|---|---|---|
| Culture | B | Strong hierarchy | ✓ | ✓ | 2,4,7,10 |
| F | Established means of formal and informal communication | ✓ | ✓ | All | |
| Involvement | F | Shared-decision making | ✓ | ✓ | 1,3,6,8,11,12,13 |
| Resources | B | Lack of necessary equipment | ✓ | ✓ | 4,5,6,8,9,10,12 |
| B | Lack of staff technical expertise | ✓ | ✓ | 2,4,5,6, 8,9,10 | |
| B | Poor technical support | ✓ | 9,10 | ||
| F | Access to necessary equipment | ✓ | ✓ | 1,2,3,7,11,13 | |
| F | Staff with necessary technical skills | ✓ | 11,12,13 | ||
| F | Patients access to resources | ✓ | 8,9,10,11,12,13 | ||
| Process and systems | B | Disturbance of workflow | ✓ | ✓ | 1,9,10 |
| F | Well fit with practice routine | ✓ | ✓ | 1,2,3,7,8,9,10,11,12,13 | |
| Relationship | B | Downgrade with patient's personal relationship | ✓ | ✓ | 1,3,8,9,10,11,12,13 |
| F | Maintenance of good patient relationship | ✓ | ✓ | 2,3,4,5,6, 8,10,11,12,13 | |
| Patient characteristics | B | Older patients | ✓ | ✓ | 2,3,4,5,6,7 8,9,10,11,12,13 |
| F | Older patients that want to reduce the risk of infection | ✓ | 2 | ||
| F | Younger/working-age patients | ✓ | 8,10,11,12,13 | ||
| F | Younger/working-age, chronic patients | ✓ | 1,3,4,5,6,7 |
Required less new equipment.
Professional level: comparison of Hong Kong and The Netherlands (✓ Mentioned ✗Not mentioned).
| Category | Barrier (B) or Facilitator (F) | Factor | Hong Kong | The Netherlands | Participants |
|---|---|---|---|---|---|
| Attitude to change | B | Negative attitude to change | ✓ | ✗ | 5 |
| F | Positive attitude to change | ✓ | ✓ | 1,2,3,4,6,7,8,9,10,11,12,13 | |
| B | Negative peer experiences | ✓ | ✓ | 4,5,9,12,13 | |
| F | Positive peer experiences | ✓ | ✓ | 1,2,3,6, 8,10,11,12,13 | |
| Ability to do practice | B | Limited range of diseases that can be managed through teleconsultation | ✓ | ✓ | All |
| B | Patient limited trust on remote diagnosis | ✓ | ✗ | 6,7 | |
| B | Unfit with personal style of delivering care | ✗ | ✓ | 8,9,12 | |
| F | Fit with personal style of delivering care | ✗ | ✓ | 10,11,13 | |
| Perceived utility | F | Positive perceived utility | ✓ | ✓ | All |
| Competency | B | Insufficient technical skills | ✗ | ✓ | 9 |
| F | Sufficient technical skills | ✗ | ✓ | 8,10,11,12,13 | |
| F | Knowledge on teleconsultation | ✓ | ✓ | 1,2,3,5,7,11,12,13 |
Including: chronic diseases management1,2,3,4,5,6,7,12, new born care7, pandemics managementAll, triaging3,5,8,9,10,11,12,13, COVID-19 remote managementAll, convenience for patient1,3,4,6,7,8,9,10,11,12,13 and practice2,6,8,9,11,12,13, lower threshold to contact practioner10,11,12, make care more accessible to people with reduced mobility8,12, treating simpler issuesl, and provide educations on medical treatments9.
Intervention level: comparison of Hong Kong and The Netherlands (✓ Mentioned ✗Not mentioned).
| Category | Barrier (B) or Facilitator (F) | Factor | Hong Kong | The Netherlands | Participants |
|---|---|---|---|---|---|
| Implementability | B | Need of new equipment | ✓ | ✓ | 4,6, 8,9,10 |
| F | Low complexity intervention | ✓ | ✓ | 1,3,8,9,10,11,12,13 | |
| F | Long term sustainability | ✓ | ✓ | 1,2,3,4,6,7,8,9,10,11,12,13 | |
| Nature of the intervention | B | Limited degree of intervention customization | ✓ | ✓ | 1,2,3,7,8,9,10,11,12,13 |
| B | High complexity intervention | ✓ | 9 | ||
| F | Low complexity intervention | ✓ | ✓ | 1,3,8,10,11,12,13 | |
| F | Increased flexibility in the routine | ✓ | ✓ | 1,2,3,7,8,9,10,11,12,13 | |
| Safety and data security | B | Concerns on data privacy | ✓ | ✓ | 1,2,3,4,5,6,7,9,10 |
| F | Patient lack of data concerns | ✓ | ✓ | 1,3,8,9,10,11,12,13 | |
| F | Added patient privacy | ✓ | 1 | ||
| F | Trust in higher entities | ✓ | 8,9,10,11,12,13 |
Participants 11,12,13 already had the necessary equipment available.